본문 바로가기
KERD
논문KCI 등재

Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

The biologically active compounds derived from different natural organisms such as animals, plants, and microorganisms like algae, fungi, bacteria and merine organisms. These natural compounds possess diverse biological activities like anthelmintic, antibacterial, antifungal, antimalarial, antiprotozoal, antituberculosis, and antiviral activities. These biological active compounds were acted by variety of molecular targets and thus may potentially contribute to several pharmacological classes. The synthesis of natural products and their analogues provides effect of structural modifications on the parent compounds which may be useful in the discovery of potential new drug molecules with different biological activities. Natural organisms have developed complex chemical defense systems by repelling or killing predators, such as insects, microorganisms, animals etc. These defense systems have the ability to produce large numbers of diverse compounds which can be used as new drugs. Thus, research on natural products for novel therapeutic agents with broad spectrum activities and will continue to provide important new drug molecules.

Abstract

The biologically active compounds derived from different natural organisms such as animals, plants, and microorganisms like algae, fungi, bacteria and merine organisms. These natural compounds possess diverse biological activities like anthelmintic, antibacterial, antifungal, antimalarial, antiprotozoal, antituberculosis, and antiviral activities. These biological active compounds were acted by variety of molecular targets and thus may potentially contribute to several pharmacological classes. The synthesis of natural products and their analogues provides effect of structural modifications on the parent compounds which may be useful in the discovery of potential new drug molecules with different biological activities. Natural organisms have developed complex chemical defense systems by repelling or killing predators, such as insects, microorganisms, animals etc. These defense systems have the ability to produce large numbers of diverse compounds which can be used as new drugs. Thus, research on natural products for novel therapeutic agents with broad spectrum activities and will continue to provide important new drug molecules.

참고문헌 (219)

  1. Akilov OE, "Clinical manifestations and classification of Old World cutaneous leishmaniasis", Int J Dermatol, 46, pp.132~142 (2007)
  2. Aneiros A, "Bioactive peptides from marine sources : pharmacological properties and isolation procedures", J Chromatogr B : Analyt Technol Biomed Life Sci, 803, pp.41~53 (2004)
  3. Ankisetty S, "Further Membranolide Diterpenes from the Antarctic Sponge Dendrilla membranosa", J Nat Prod, 67, pp.1172~1174 (2004)
  4. Aoki S, "Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis", Bioorg Med Chem, 11, pp.1969~1973 (2003)
  5. Ata A, "New antibacterial diterpenes from Pseudopterogorgia elisabethae", Helv Chim Acta, 87, pp.1090~1098 (2004)
  6. Bernan VS, "Mining marine microorganisms as a source of new antimicrobials and antifungals", Curr Med Chem Anti-Infect Agents, 3, pp.181~195 (2004)
  7. Boelaert M, "How better drugs could change kala-azar control. Lessons from a costeffectiveness analysis", Trop Med Int Health, 7, pp.955~959 (2002)
  8. Boulahbal F, "Reichman and Hershfield's Tuberculosis", pp.29~47 (2006), nforma Healthcare USA Inc
  9. Breman J, "The ears of the hippopotamus : manifestations, determinants, and estimates of the malaria burden", Am J Trop Med Hyg, 64, pp.1~ (2001)
  10. Bugni TS, "Kalihinols from two Acanthella cavernosa sponges : Inhibitors of bacterial folate biosynthesis", Tetrahedron, 60, pp.6981~6988 (2004)
  11. Buss AD, "Burger's Medicinal Chemistry and Drug Discovery, Volume 1: Principals and Practice", pp.983~1034 (1995), Wiley
  12. Butler MS, "Natural products to drugs : natural product derived compounds in clinical trials", Nat Prod Rep, 22, pp.162~195 (2005)
  13. Capon RJ, "Nematocidal thiocyanatins from a southern Australian marine sponge, Oceanapia sp", J Nat Prod, 67, pp.1277~1282 (2004)
  14. "Chagas Disease Fact Sheet"[URL]
  15. Chang L, "Crambescidin 826 and dehydrocrambine A: New polycyclic guanidine alkaloids from the marine sponge Monanchora sp. That inhibit HIV-1 fusion", J Nat Prod, 66, pp.1490~1494 (2003)
  16. Chill L, "New sesterterpenes from Madagascan Lendenfeldia sponges", Tetrahedron, 60, pp.10619~10626 (2004)
  17. Chin YW, "Drug discovery from natural sources", APPS Journal, 8, pp.E239~E253 (2006)
  18. Cho SH, "Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis", Antimicrob Agents Chemother, 51, pp.1380~1385 (2007)
  19. Coker HAB, "The Malaria. Scourge. Concepts in Disease Management", The Nig J Pharm, 32, pp.19~47 (2000)
  20. Copp BR, "Natural product growth inhibitors of Mycobacterium tuberculosis", Nat Prod Rep, 24, pp.278~297 (2007)
  21. Copp BR, "Antimycobacterial natural products", Nat Prod Rep, 20, pp.535~557 (2003)
  22. Cragg GM, "Introduction. AnticancerAgents from Natural Products", pp.1~3 (2005), Taylor & Francis
  23. De Oliveira JH, "Ingenamine G and cyclostellettamines G-I, K, and L from the new Brazilian species of marine sponge Pachychalina sp", J Nat Prod, 67, pp.1685~1689 (2004)
  24. Desjeux P, "Leishmania", HIV co-infections:epidemiology in Europe, 2003, pp.97, 3~15
  25. Dmitrenok AS, "New lipids from the soft corals of the Andaman Islands", Russ Chem Bull, 52, pp.1868~1872 (2003)
  26. Donaghy L, "Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen(HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis", Clin Exp Immunol, 147, pp.236~240 (2007)
  27. Donia M, "Marine natural products and their potential applications as anti-infective agents", Lancet Infect Dis, 3, pp.338~348 (2003)
  28. Edwards DJ, "Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula", Chem Biol, 11, pp.817~833 (2004)
  29. Ekthawatchai S, "Synthetic and naturally occurring antimalarials", J Heterocyclic Chem, 36, pp.1599~1605 (1999)
  30. Endo T, "Nagelamides A-H, new dimeric bromopyrrole alkaloids from marine sponge Agelas species", J Nat Prod, 67, pp.1262~1267 (2004)
  31. Erdogan-Orhan I, "Polyprenyl-hydroquinones and-furans from three marine sponges inhibit the cell cycle regulating phosphatase CDC25A", Nat Prod Res, 18, pp.1~9 (2004)
  32. Fennell BJ, "Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum", J Antimicrob Chemother, 51, pp.833~841 (2003)
  33. Fernandez-Busquets X, "Circular proteoglycans from sponges : first members of the spongican family", Cell Mol Life Sci, 60, pp.88~112 (2003)
  34. Fotie J, "In-vivo antimalarial activity of some oxygenated xanthones", Ann Trop Med Parasitol, 97, pp.683~688 (2003)
  35. Frenz JL, "Marine natural products as therapeutic agents: Part 2", Exp Opin Therap. Patents, 14, pp.17~33 (2004)
  36. Fujita M, "Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai", J Am Chem Soc, 125, pp.15700~15701 (2003)
  37. Fujita M, "Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata", J Nat Prod, 66, pp.569~571 (2003)
  38. Gessler MC, "Screening Tanzanian medicinal plants for antimalarial activity", Acta Tropica, 56, pp.65~77 (1994)
  39. Go ML, "Novel antiplasmodial agents", Med Res Rev, 23, pp.456~487 (2003)
  40. Gochfeld DJ, "Marine natural products as lead anti-HIV agents", Mini Rev Med Chem, 3, pp.401~424 (2003)
  41. Golenser J, "Current perspectives on the mechanism of action of artemisinins", Int J Parasitol, 36, pp.1427~1441 (2006)
  42. Gompel M, "Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum", Bioorg Med Chem Lett, 14, pp.1703~1707 (2004)
  43. Goud TV, "Anti-HIV active petrosins from the marine sponge Petrosia similis", Biol Pharm Bull, 26, pp.1498~1501 (2003)
  44. Goud TV, "Two new bromotyrosine-derived metabolites from the sponge Psammaplysilla purpurea", Chem. Pharm. Bull (Tokyo), 51, pp.990~993 (2003)
  45. Grant MA, "Conotoxins and Structural Biology: A Prospective Paradigm for Drug Discovery", Curr Prot Pept Sci, 5, pp.235~248 (2004)
  46. Griffith KS, "Treatment of malaria in the United States : a systematic review", JAMA, 297, pp.2264~2277 (2007)
  47. Gu QJ, "Cytotoxic and Antimicrobial Constituents of the Bark of Diospyros maritima Collected in Two Geographical Locations in Indonesia", J Nat Prod, 67, pp.1156~1161 (2004)
  48. Gunasekera SP, "Two new xanthones, calozeyloxanthone and zeyloxanthonone, from Calophyllum zeylanicum(Guttiferae)", J Chem Soc, Perkin Transactions, 1, pp.1831~1835 (1981)
  49. Gustafson KR, "Antiviral marine natural products", Curr Med Chem, 3, pp.233~249 (2004)
  50. Hassan W, "New Imidazole Alkaloids from the Indonesian Sponge Leucetta chagosensis", J Nat Prod, 67, pp.817~822 (2004)
  51. Hay A-E, "Antioxidant xanthones from Garcinia vieillardii", J Nat Prod, 67, pp.707~709 (2004)
  52. Hay A-E, "Antifungal chromans inhibiting the mitochondrial respiratory chain of pea seeds and new xanthones from Calophyllum caledonicum", Planta Med, 69, pp.1130~1135 (2003)
  53. Hay AE, "Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii", Life Sci, 75, pp.3077~3085 (2004)
  54. Haynes RK, "Artemisone--a highly active antimalarial drug of the artemisinin class", Angew Chem Int Ed, 45, pp.2082~2088 (2006)
  55. Haynes RK, "From artemisinin to new artemisinin antimalarials : biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements", Curr Top Med Chem, 6, pp.509~537 (2006)
  56. Helesbeux JJ, "Synthesis of 2-hydroxy-3-methylbut-3-enyl substituted coumarins and xanthones as natural products. Application of the Schenck ene reaction of singlet oxygen with ortho-prenylphenol precursors", Tetrahedron, 60, pp.2293~2300 (2004)
  57. Hirono M, "Acylspermidine derivatives isolated from a soft coral, Sinularia sp, inhibit plant vacuolar H(+)-pyrophosphatase", J Biochem, 133, pp.811~816 (2003)
  58. Hong S, "In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges", Naunyn-Schmiedeberg's Arch Pharmacol, 368, pp.448~456 (2003)
  59. Hu J, "Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein", J Pharm Sci, 95, pp.248~255 (2004)
  60. Ignatuschenko MV, "Xanthones as antimalarial agents; studies of a possible mode of action", FEBS Lett, 409, pp.67~73 (1997)
  61. Iijima R, "A novel antimicrobial peptide from the sea hare Dolabella auricularia", Dev Comp Immunol, 27, pp.305~311 (2003)
  62. Iinuma M, "Two xanthones from root bark of Calophyllum inophyllum", Phytochem, 35, pp.527~532 (1994)
  63. Isnansetyo A, "MC21-A, a Bactericidal Antibiotic Produced by a New Marine Bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against Methicillin-Resistant Staphylococcus aureus", Antimicrob. Agents Chemother, 47, pp.480~488 (2003)
  64. Ito C, "A Novel Dibenzofuran and Two New Xanthones form Calophyllum panciflorum", Chem & Pharm Bull, 44, pp.441~443 (1996)
  65. Iwasa K, "Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity", Eur J Med Chem, 34, pp.1077~1083 (1999)
  66. Jacob MR, "Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9alpha, 11alpha-epoxycholest-7-ene-3beta, 5alpha, 6alpha, 19-tetrol 6-acetate", J Nat Prod, 66, pp.1618~1622 (2003)
  67. Janin YL, "Antituberculosis drugs : ten years of research", Bioorg Med Chem, 15, pp.2479~2513 (2007)
  68. Ya Hong Jiang, "Antioxidant Activity of (8E,13Z,20Z)-Strobilinin(7E,13Z,20Z)-Felixinin from a Marine Sponge Psammocinia sp", Natural Product Sciences, 10(6), pp.272~276 (2004), 한국생약학회
  69. Jung M, "Naturally occurring peroxides with biological activities", Mini Rev Med Chem, 3, pp.159~165 (2003)
  70. Kamei Y, "Sargaquinoic acid promotes neurite outgrowth via protein kinase A and MAP kinases-mediated signaling pathways in PC12D cells", Int J Dev Neurosci, 21, pp.255~262 (2003)
  71. Kaneko M, "Structure of a New Neuritogenic-Active Ganglioside from the Sea Cucumber Stichopus japonicus", Eur J Org Chem, 2003, pp.1004~1008 (2003)
  72. Kehraus S, "Novel amino acid derived naturalproducts from the ascidian Atriolum robustum : identification and pharmacological characterization of a unique adenosine derivative", J Med Chem, 47, pp.2243~2255 (2004)
  73. Keyzers RA, "Anti-inflammatory metabolites from marine sponges", Chem Soc Rev, 34, pp.355~365 (2005)
  74. Keyzers RA, "Clathriol B, a new 14beta marine sterol from the New Zealand sponge Clathria lissosclera", Aust J Chem, 56, pp.279~282 (2003)
  75. Keyzers RA, "Novel antiinflammatory Spongian Diterpenes from the New Zealand Marine Sponge Chelonaplysilla violacea", Eur J Org Chem, 2004, pp.419~425 (2004)
  76. Kobayashi M, "Indonesian medicinal plants. XXI. Inhibitors of Na+", H+exchanger from the bark of Erythrina variegate and the roots of Maclura cochinchinensis, 1997, pp.45, 1615~1619
  77. Kossuga MH, "(2S, 3R)-2-aminododecan-3-ol, a new antifungal agent from the ascidian Clavelina oblonga", J Nat Prod, 67, pp.1879~1881 (2004)
  78. Kouam TNM, "Bipendensin, an unusual phenolic acetal from Afzelia bipendensis", Nat Prod Lett, 3, pp.299~303 (1993)
  79. Krishnaiah P, "New lamellarin alkaloids from the Indian ascidian Didemnum obscurum and their antioxidant properties", J Nat Prod, 67, pp.1168~1171 (2004)
  80. Kuo YH, "Cytotoxic constituents from the stems of Diospyros maritima", Planta Med, 63, pp.363~365 (1997)
  81. Lakshmi V, "The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae", Parasitol Res, 93, pp.468~474 (2004)
  82. Laurent D, "Natural-product diversity of the New Caledonian marine ecosystem compared to other ecosystems : a pharmacologically oriented view", Chem Biodiv, 1, pp.539~594 (2004)
  83. Lee EH, "Structureactivity relationship of lysophosphatidylcholines in HL-60human leukemia cells", Acta Pharmacol Sin, 25, pp.1521~1524 (2004)
  84. Likhitwitayawuid K, "Antimalarials from Stephania venosa, Prismatomeris sessiliflora, Diospyros montana and Murraya siamensis", Planta Med, 65, pp.754~756 (1999)
  85. Soon Sung Lim, "In vitro Antimalarial Activity of Flavonoids and Chalcones", Bulletin of the Korean Chemical Society, 28(12), pp.2495~2497 (2007), 대한화학회
  86. Lippert H, "Antimicrobial activity in sub-Arctic marine invertebrates", Polar Biol, 26, pp.591~600 (2003)
  87. Liu J, "Tuberculosis : Current Treatment and New Drug Development", Anti-Infective Agents in Med Chem, 5, pp.331~344 (2006)
  88. Livett BG, "Drugs from the sea : conopeptides as potential therapeutics", Curr Med Chem, 11, pp.1715~1723 (2004)
  89. Lucas R, "Cycloamphilectenes, a new type of potent marine diterpenes : inhibition of nitric oxide production in murine macrophages", Life Sci, 72, pp.2543~2552 (2003)
  90. Lucas R, "Modulatory effect of bolinaquinone, a marine sesquiterpenoid, on acute and chronic inflammatory processes", J Pharmacol Exp Ther, 304, pp.1172~1180 (2003)
  91. Luescher-Mattli M, "Anti-infective Agents", Curr Med Chem, 2, pp.219~225 (2003)
  92. Lukes J, "Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy", Proc Natl Acad Sci USA, 104, pp.9375~9380 (2007)
  93. Luque-Ortega JR, "Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes", Antimicrob Agents Chemother, 51, pp.1327~1332 (2007)
  94. Marrero J, "Bielschowskysin, a gorgonianderived biologically active diterpene with an unprecedented carbon skeleton", Org Lett, 6, pp.1661~1664 (2004)
  95. Masaba SC, "The antimalarial activity of Vernonia amygdalina Del(Compositae)", Trans Roy Soc Trop Med Hyg, 94, pp.694~695 (2000)
  96. Maskey RP, "Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry", J Antibiot, 57, pp.771~779 (2004)
  97. Masuno MN, "Relationship between body mass index and anti-hypertensive efficacy of doxazosin according to a survey of Japanese patients", Mar Drugs, 2, pp.176~184 (2004)
  98. Matsubara K, "Recent advances in marine algal anticoagulants", Curr Med Chem, 2, pp.13~19 (2004)
  99. Mayer AMS, "Marine pharmacology in 1999 : compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action", Comp Biochem Physiol C Toxicol Pharmacol, 132, pp.315~339 (2002)
  100. Mayer AMS, "Marine pharmacology in 2000:marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action", Mar Biotechnol (NY), 6, pp.37~52 (2004)
  101. Mayer AMS, "Marine pharmacology in 2001-2002 : Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action", Comp Biochem Physiol Part C Pharmacol Toxicol, 140, pp.265~286 (2004)
  102. Mayer AMS, "Marine pharmacology in 1998 : Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, anthelmintic, antiplatelet, antiprotozoal, and antiviral activities; with actions on the cardiovascular, endocrine, immune, and nervous systems; and other miscellaneous mechanisms of action", Pharmacologist, 42, pp.62~69 (2000)
  103. Mayer AMS, "Marine pharmacology in 2003-4 : marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action", Compa Biochem Physiol C Toxicol Pharmacol, 145, pp.553~581 (2007)
  104. McClelland D, "Irreversible and reversible pore formation by polymeric alkylpyridinium salts(poly-APS)from the sponge Reniera sarai", Br J Pharmacol, 139, pp.1399~1408 (2003)
  105. Meiyu G, "The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4molecule", Antivir Res, 59, pp.127~135 (2003)
  106. Melo FR, "Antithrombinmediated anticoagulant activity of sulfated polysaccharides : different mechanisms for heparin and sulfated galactans", J Biol Chem, 279, pp.20824~20835 (2004)
  107. Mendis K, "The neglected burden of Plasmodium vivax malaria", Am J Trop Med Hyg, 64, pp.97~ (2001)
  108. Miao B, "Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome(AIDS)drug candidate, targeting CD4 in lymphocytes", Biochem Pharmacol, 68, pp.641~649 (2004)
  109. Miljanich GP, "Ziconotide : neuronal calcium channel blocker for treating severe chronic pain", Curr Med Chem, 11, pp.3029~3040 (2004)
  110. Minami H, "Novel xanthones with superoxide scavenging activity from Garcinia subelliptica", Chem Pharm Bull, 43, pp.347~349 (1995)
  111. Molinski TF, "Anti-Infect. Agents", Curr Med Chem, 3, pp.197~220 (2004)
  112. Monti MC, "Further insights on the structural aspects of PLA(2)inhibition by gamma-hydroxybutenolide-containing natural products : a comparative study on petrosaspongiolides M-R", Bioorg Med Chem, 12, pp.1467~1474 (2004)
  113. Morel C, "New xanthones from Calophyllum caledonicum", J Nat Prod, 63, pp.1471~1474 (2000)
  114. Morel C, "New and antifungal xanthones from Calophyllum caledonicum", Planta Medica, 68, pp.41~44 (2002)
  115. Mourao PA, "Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives", Curr Pharm Des, 10, pp.967~981 (2004)
  116. Mukku VJ, "New sesquiterpene quinols from a Micronesian sponge, Aka sp", J Nat Prod, 66, pp.686~689 (2003)
  117. Nakao Y, "Penasulfate A, a new alpha-glucosidase inhibitor from a marine sponge Penares sp", J Nat Prod, 67, pp.1346~1350 (2004)
  118. Nakao Y, "Identification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp", Mar Drugs, 2, pp.55~62 (2004)
  119. Namikoshi M, "Manoalide derivatives from a marine sponge Luffariella sp. collected in Palau", Fish Sci, 70, pp.152~158 (2004)
  120. Newman DJ, "Natural products as sources of new drugs over the period 1981-2002", J Nat Prod, 66, pp.1022~1037 (2003)
  121. Newman DJ, "Natural products as sources of new drugs over the last 25 years", J Nat Prod, 70, pp.461~477 (2007)
  122. Nicholas GM, "Inhibition and kinetics of mycobacterium tuberculosis and mycobacterium smegmatis mycothiol-Sconjugate amidase by natural product inhibitors", Bioorg Med Chem, 11, pp.601~608 (2003)
  123. Nika K, "Specific recognition of immune cytokines by sulphated polysaccharides from marine algae", Eur J Phycol, 38, pp.257~264 (2003)
  124. Nishimura S, "Massadine, a novel geranylgeranyltransferase type I inhibitor from the marine sponge Stylissa aff. massa", Org Lett, 5, pp.2255~2257 (2003)
  125. Oger JM, "First 2-hydroxy-3-methylbut-3-enyl substituted xanthones isolated from plants : structure elucidation, synthesis and antifungal activity", Nat Prod Res, 17, pp.195~199 (2003)
  126. Ohgami K, "Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo", Invest Ophthalmol Visual Sci, 44, pp.2694~2701 (2003)
  127. Oku N, "Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi", J Nat Prod, 67, pp.1407~1411 (2004)
  128. Opsenica D, "Antimalarial, antimycobacterial and antiproliferative activity of phenyl substituted mixed tetraoxanes", J Serb Chem Soc, 68, pp.291~302 (2003)
  129. Ospina CA, "Briarellins J-P and polyanthellin A : new eunicellin-based diterpenes from the gorgonian coral Briareum polyanthes and their antimalarial activity", J Nat Prod, 66, pp.357~363 (2003)
  130. Ovchinnikova TV, "Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina", FEBS Lett, 577, pp.209~214 (2004)
  131. Oyewole IO, "Anti-malarial and repellent activities of Tithonia diversifolia (Hemsl.) leaf extracts", J Med Plants Res, 2, pp.171~175 (2008)
  132. Pan W, "Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization", J Biochem, 135, pp.297~304 (2004)
  133. Pascual I, "Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain", Int J Biochem Cell Biol, 36, pp.138~152 (2004)
  134. Paterson I, "Chemistry. The renaissance of natural products as drug candidates", Science, 310, pp.451~453 (2005)
  135. Patrzykat A, "Gone gene fishing : how to catch novel marine antimicrobials", Trends Biotechnol, 21, pp.362~369 (2003)
  136. Patrzykat A, "Novel antimicrobial peptides derived from flatfish genes", Antimicrob Agents Chemother, 47, pp.2464~2470 (2003)
  137. Pereira HS, "Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1(HIV-1)", Antivir Res, 64, pp.69~76 (2004)
  138. Perez M, "Inhibition by Aplidine of the aggregation of the prion peptide PrP 106-126 into betasheet fibrils", Biochim Biophys Acta, 1639, pp.133~139 (2003)
  139. Pettit RK, "Antibacterial activity of the marine sponge constituent cribrostatin 6", J Med Microbiol, 53, pp.61~65 (2004)
  140. Pimentel SM, "Platelet aggregation inhibitors from Philippine marine invertebrate samples screened in a new microplate assay", Mar Biotechnol, 5, pp.395~400 (2003)
  141. Portela C, "Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite", Bioorg & Med Chem, 12, pp.3313~3321 (2004)
  142. Posadas I, "Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation", Br J Pharmacol, 138, pp.1571~1579 (2003)
  143. Posadas I, "Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M", Biochem Pharmacol, 65, pp.887~895 (2003)
  144. Potterat O, "Natural Products in Drug Discovery-Concepts and Approaches for Tracking Bioactivity", Curr Org Chem, 10, pp.899~920 (2006)
  145. Proksch P, "Detection of pharmacologically active natural products using ecology : selected examples from indopacific marine invertebrates and sponge-derived fungi", Pure Appl Chem, 75, pp.343~352 (2003)
  146. Proksch P, "Sponges (Porifera)", pp.117~142 (2003), Springer-Verlag
  147. Qi J, "Linckosides C-E, three new neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata", Bioorg Med Chem, 12, pp.4259~4265 (2004)
  148. Radhika P, "5Alpha-reductase inhibition activity of steroids isolated from marine soft corals", Steroids, 69, pp.439~444 (2004)
  149. Rao KV, "New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge", J Nat Prod, 66, pp.823~828 (2003)
  150. Rath G, "Xanthones from Hypericum roeperanum", Phytochem, 43, pp.513~520 (1996)
  151. Rezwan M, "Breaking down the wall : fractionation of mycobacteria", J Microbiol Methods, 68, pp.32~39 (2007)
  152. Rifai S, "Antimicrobial Activity of Untenospongin B, a Metabolite from the Marine Sponge Hippospongia communis collected from the Atlantic Coast of Morocco", Mar Drugs, 2, pp.147~153 (2004)
  153. Rijal S, "Antimonial treatment of visceral leishmaniasis : are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?", Microbes Infect, 9, pp.529~535 (2007)
  154. Roch P, "Antiprotozoan and Antiviral Activities of Non-cytotoxic Truncated and Variant Analogues of Mussel Defensin", Evid Based Complement Alternat Med, 1, pp.167~174 (2004)
  155. Rodríguez II, "Homopseudopteroxazole, a new antimycobacterial diterpene alkaloid from Pseudopterogorgia elisabethae", J Nat Prod, 66, pp.855~857 (2003)
  156. Rodríguez II, "New pseudopterosin and seco-pseudopterosin diterpene glycosides from two Colombian isolates of Pseudopterogorgia elisabethae and their diverse biological activities", J Nat Prod, 67, pp.1672~1680 (2004)
  157. Sakai R, "Isolations of N-methyl-D-aspartic acid-type glutamate receptor ligands from Micronesian sponges", J Nat Prod, 66, pp.784~787 (2003)
  158. Sakai R, "Novel betaines from a micronesian sponge Dysidea herbacea", J Org Chem, 69, pp.1180~1185 (2004)
  159. Salem MM, "Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis", Curr Med Chem, 13, pp.2571~2598 (2006)
  160. Sandsdalen E, "The antibacterial effect of a polyhydroxylated fucophlorethol from the marine brown alga, Fucus vesiculosus", World J Microbiol Biotechnol, 19, pp.777~782 (2003)
  161. Satitpatipan V, "New nitrogenous Germacranes from a Thai marine sponge, Axinyssa n. sp", J Nat Prod, 67, pp.503~505 (2004)
  162. Savoia D, "Antimicrob. Antimicrobial activity of euplotin C, the sesquiterpene taxonomic marker from the marine ciliate Euplotes crassus", Antimicrob Agents Chemother, 48, pp.3828~3833 (2004)
  163. Schluger NW, "The pathogenesis of tuberculosis : the first one hundred(and twenty-three)years", Am J Respir Cell Mol Biol, 32, pp.251~256 (2005)
  164. Schmitz FJ, "Marine Biotechnology, Pharmaceutical and Bioactive Natural Products, vol 1", pp.197~308 (1993), Plenum Press
  165. Schupp P, "Eudistomins W and X, two new beta-carbolines from the micronesian tunicate Eudistoma sp", J Nat Prod, 66, pp.272~275 (2003)
  166. Sharpe IA, "Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+dependence, and structure-activity relationship", J Biol Chem, 278, pp.40317~40323 (2003)
  167. Smith I, "Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence", Clin Microbiol Rev, 16, pp.463~496 (2003)
  168. Somoskovi A, "Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications : Identification of a speciesspecific pncA mutation in"Mycobacterium canettii"and the reliable and rapid predictor of pyrazinamide resistance", J Clin Microbiol, 45, pp.595~599 (2007)
  169. Soto J, "Treatment of New World cutaneous leishmaniasis with miltefosine", Trans R Soc Trop Med Hyg, 100suppl1, pp.S34~S40 (2006)
  170. Staats PS, "Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS : a randomized controlled trial", JAMA, 291, pp.63~70 (2004)
  171. Sudarslal S, "Sodium channel modulating activity in a deltaconotoxin from an Indian marine snail", FEBS Lett, 553, pp.209~212 (2003)
  172. Sultanbawa MUS, "Xanthonoids of tropical plants", Tetrahedron, 36, pp.1465~1506 (1980)
  173. Takada K, "Schulzeines A-C, new alpha-glucosidase inhibitors from the marine sponge Penares schulzei", J Am Chem Soc, 126, pp.187~193 (2004)
  174. Takamatsu S, "Marine natural products as novel antioxidant prototypes", J Nat Prod, 66, pp.605~608 (2003)
  175. Theerachayanan T, "Antimalarial and antimycobacterial activities of dimeric naphthoquinones from Diospyros glandulosa and Diospyros rhodocalyx", CMU J Nat Sci, 6, pp.253~259 (2007)
  176. "Tuberculosis (TB)"[URL]
  177. Tincu JA, "Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes", J Biol Chem, 278, pp.13546~13553 (2003)
  178. Tincu JA, "Antimicrobial peptides from marine invertebrates. Antimicrob", Agents Chemother, 48, pp.3645~3654 (2004)
  179. Tiruviluamala P, "Tuberculosis", Annu Rev Public Health, 23, pp.403~426 (2002)
  180. Tosuji H, "Calyculin A causes the activation of histone H1 kinase and condensation of chromosomes in unfertilized sea urchin eggs independently of the maturationpromoting factor", Comp Biochem Physiol Part C Pharmacol, 135, pp.415~424 (2003)
  181. Trager W, "Human malaria parasites in continuous culture", Science, 193, pp.673~677 (1976)
  182. Tran QL, "In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine", J Ethnopharmacol, 86, pp.249~252 (2003)
  183. Trevisi L, "Callipeltin A : sodium ionophore effect and tension development in vascular smooth muscle", Biochem Pharmacol, 68, pp.1331~1338 (2004)
  184. Tsai MC, "Characterization of the tuberculous granuloma in murine and human lungs : cellular composition and relative tissue oxygen tension", Cell Microbiol, 8, pp.218~232 (2006)
  185. Tsang CK, "Sargaquinoic acid supports the survival of neuronal PC12D cells in a nerve growth factor-independent manner", Eur J Pharmacol, 488, pp.11~18 (2004)
  186. Tsukamoto S, "Aspermytin A : a new neurotrophic polyketide isolated from a marine-derived fungus of the genus Aspergillus", Bioorg Med Chem Lett, 14, pp.417~420 (2004)
  187. Tsukamoto S, "New polyhydroxy sterols : proteasome inhibitors from a marine sponge Acanthodendrilla sp", J Nat Prod, 66, pp.1181~1185 (2003)
  188. Tsukamoto S, "Parguerol and isoparguerol isolated from the Sea Hare, Aplysia kurodai, induce neurite outgrowth in PC-12 cells", Mar Drugs, 2, pp.170~175 (2004)
  189. Tucker SJ, "The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells", Biochim Biophys Acta, 1614, pp.171~181 (2004)
  190. Tziveleka LA, "Natural products with antiHIV activity from marine organisms", Curr Top Med Chem, 3, pp.1512~1535 (2003)
  191. Uchida T, "Crystal structure of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata : implications of domain structure for its membrane pore-formation mechanism", J Biol Chem, 279, pp.37133~37141 (2004)
  192. Verbitski SM, "Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity", J Med Chem, 47, pp.2062~2070 (2004)
  193. Vetvicka V, "Effects of marine beta-1, 3 glucan on immune reactions", Int Immunopharmacol, 4, pp.721~730 (2004)
  194. Villar RM, "Evaluation of the effects of several zoanthamine-type alkaloids on the aggregation of human platelets", Bioorg Med Chem, 11, pp.2301~2306 (2003)
  195. Wang CY, "Melophlins C-O, thirteen novel tetramic acids from the marine sponge Melophlus sarassinorum", J Nat Prod, 66, pp.51~56 (2003)
  196. Wei X, "Antiplasmodial cembradiene diterpenoids from a Southwestern Caribbean gorgonian octocoral of the genus Eunicea", Tetrahedron, 60, pp.11813~11819 (2004)
  197. "Malaria"[URL]
  198. Willert EK, "Allosteric regulation of an essential trypanosome polyamine biosynthetic enzyme by a catalytically dead homolog", Proc Natl Acad Sci USA, 104, pp.8275~8280 (2007)
  199. Williams DE, "Spirastrellolide A: revised structure, progress toward the relative configuration, and inhibition of protein phosphatase 2A", Org Lett, 6, pp.2607~2610 (2004)
  200. Williams DE, "Meroterpenoid MAPKAP (MK2) inhibitors isolated from the indonesian marine sponge Acanthodendrilla sp", J Nat Prod, 67, pp.2127~2129 (2004)
  201. Wonganuchitmeta SN, "Antitubercular sesterterpenes from the Thai sponge Brachiaster sp", J Nat Prod, 67, pp.1767~1770 (2004)
  202. "New Plan to Contain DrugResistant TB" (2007)[URL]
  203. Report of the Scientific Working Group on Chagas Disease Buenos Aires, Argentina 17-20 April 2005, "World Health Organization", WHO, ~ (2005)
  204. Report of the WHO Informal Consultation on the Evaluation and Testing of Insecticides. CTD, "WHOPES", IC. Control of Tropical Diseases Division, World Health Organization, pp.1996, 69~
  205. World Health Organization, "The Promotion and development of traditional medicine", World Health Organization, ~ (1978)
  206. World Health Organization, "The world health report 1998-Life in the 21st century : a vision for all", World Health Organization, 98~ (1998)
  207. World Health Organization, "What Is Malaria?", World Health Organization, ~ (2001)
  208. Xu N, "Antibacterial bromophenols from the marine red alga Rhodomela confervoides", Phytochemistry, 62, pp.1221~1224 (2003)
  209. Yamada T, "Peribysins A-D, potent cell-adhesion inhibitors from a sea harederived culture of Periconia species", Org Biomol Chem, 2, pp.2131~2135 (2004)
  210. Yang SW, "A new sterol sulfate, Sch 572423, from a marine sponge, Topsentia sp", Bioorg Med Chem Lett, 13, pp.1791~1794 (2003)
  211. Yang SW, "Structure elucidation of a new antifungal sterol sulfate, Sch 575867, from a deep-water marine sponge(Family : Astroscleridae)", J Antibiot(Tokyo), 56, pp.186~189 (2003)
  212. Yang SW, "A new bicyclic guanidine alkaloid, Sch 575948, from a marine sponge, Ptilocaulis spiculifer", J Antibiot (Tokyo), 56, pp.970~972 (2003)
  213. Yang SW, "A new sesterterpene, Sch 599473, from a marine sponge, Ircinia sp", J Antibiot (Tokyo), 56, pp.783~786 (2003)
  214. Yang XD, "Xanthones from the stems of Securidaca inappendiculata", Phytochemistry, 58, pp.1245~1249 (2001)
  215. Yim JH, "Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03", Mar Biotechnol(NY), 6, pp.17~25 (2004)
  216. Yoo HD, "Isoarenarol, a new protein kinase inhibitor from the marine sponge Dysidea arenaria", Pharm Biol, 41, pp.223~225 (2003)
  217. Zancan P, "Venous and arterial thrombosis in rat models : dissociation of the antithrombotic effects of glycosaminoglycans", Blood Coagul Fibrinolysis, 15, pp.45~54 (2004)
  218. Zhang W, "Biopotentials of marine sponges from China oceans: past and future", Biomol Eng, 20, pp.413~419 (2003)
  219. ZhuW, "Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2", Int J Antimicrob Agents, 24, pp.279~283 (2004)

관련 논문AI추천

이 간행물의 다른 논문 (6건)